A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1…
Browsing: Semaglutide
Semaglutide is a medication primarily used to treat type 2 diabetes and obesity. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1 to increase insulin secretion, reduce appetite, and slow down digestion. This helps in better blood sugar control and weight loss. Semaglutide is available in injectable forms and as an oral tablet, and it has been shown in clinical trials to be highly effective in improving glycemic control and aiding significant weight loss, making it a valuable option for managing these conditions.
A new animal study raises important questions about a little-known ingredient used in oral weight-loss…
New research suggests that people using next-generation weight loss drugs may be losing weight without…
Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may…
Semaglutide may safeguard the heart even without significant weight loss. A new study led by…
Drugs used for diabetes and weight loss may also dampen alcohol’s effects by slowing how…
As GLP-1 weight-loss drugs become more common, their effects may be reshaping everyday food choices…
GLP-1 drugs like Ozempic, Trulicity and Victoza were associated with a slightly lower likelihood of…
In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors.…
GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating…
New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major…
Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss,…
New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also…
Semaglutide and Food Noise: A New Discovery New findings presented at the Annual Meeting of…
A sweeping Danish study reveals a harsh truth about today’s most popular weight-loss drug: more…
Researchers warn that widespread use of weight-loss drugs like Ozempic among women of reproductive age…
Women between the ages of 50 and 64 use medications the most. Nearly 12% of…
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments…